Maureen Leeuw – Research output — Amsterdam UMC research portal

Research activity per year

3 Article
2 Comment/Letter to the editor

5 results

2023

Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands
Boekel, L., Atiqi, S., Leeuw, M., Hooijberg, F., Besten, Y. R., Wartena, R., Steenhuis, M., Vogelzang, E., Webers, C., Boonen, A., Gerritsen, M., Lems, W. F., Tas, S. W., van Vollenhoven, R. F., Voskuyl, A. E., van der Horst-Bruinsma, I., Nurmohamed, M., Rispens, T. & Wolbink, G., 1 Jul 2023, In: The Lancet Rheumatology. 5, 7, p. e375-e385
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

5 Citations (Scopus)
2022

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study
Boekel, L., Hooijberg, F., Vogelzang, E. H., Besten, Y. R., Leeuw, M., Atiqi, S., van Vollenhoven, R. F., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Dijkshoorn, B., Bakhlakh, S., Crooijmans, J. J., Voskuyl, A., van der Horst-Bruinsma, I. E., Lems, W., Kuijpers, T. W., van Ham, S. M., Wieske, L., Eftimov, F., & 13 othersKummer, L. Y., van Dam, P. K., Stalman, E. W., Steenhuis, M., Keijzer, S., Cristianawati, O., Keijser, J., Loeff, F. C., Tas, S. W., Nurmohamed, M. T., Boers, M., Rispens, T. & Wolbink, G., 5 Apr 2022, In: RMD OPEN. 8, 1, 002035.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

12 Citations (Scopus)
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

34 Citations (Scopus)
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
Boekel, L., Hooijberg, F., Besten, Y. R., Vogelzang, E. H., Steenhuis, M., Leeuw, M., Atiqi, S., van Vollenhoven, R., Lems, W. F., Bos, W. H., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Voskuyl, A. E., van der Horst-Bruinsma, I. E., Tas, S. W., Boers, M., Rispens, T., Nurmohamed, M. T. & Wolbink, G., 1 May 2022, In: The Lancet Rheumatology. 4, 5, p. e310-e313
Research output: Contribution to journal › Comment/Letter to the editor › Academic

Open Access

12 Citations (Scopus)
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 othersBoers, M., Nurmohamed, M. T. & Wolbink, G., 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750 4 p.
Research output: Contribution to journal › Comment/Letter to the editor › Academic

Open Access

8 Citations (Scopus)